Breaking News

Evidence backing digital physical therapy companies goes under the microscope

June 6, 2024
Health Tech Correspondent

Good morning health tech readers!

Today, a look at cost savings from the very well-funded virtual care companies promising to change musculoskeletal care.

Reach me: mario.aguilar@statnews.com

policy

'Little tech' wants its voice heard on AI

As leaders in Washington mull what kinds of regulations to place on artificial intelligence, startups are doing what they can to make their concerns heard, STAT's Mohana Ravindranath reports.

While big companies like Microsoft have used their lobbying muscle and funds to make sure they're guiding regulation in the most favorable direction for the company, there are concerns that  fledgling companies may not be heard and that rules might be too onerous for small shops that don't have large compliance teams.

Venture capital firms like Y Combinator and Andreessen Horowitz, which invest in health tech companies, have appeared before Congress and lobbied behind the scenes. And the Consumer Technology Association has convened with the bipartisan Digital Health Caucus to conduct educational briefings.

Read more from Mohana about startups' efforts in DC.


digital health

PHTI strikes again

Screen Shot 2024-06-04 at 10.41.31 AM

A new report from the Peterson Health Technology Institute suggests virtual physical therapy services could decrease health care spending for payers that invest in them. Billions of dollars have been poured into these companies and the assessment could boost business among companies wary of buying their services for their populations.

The analysis looked at three kinds of solutions: App-based exercise therapy solutions, physical therapist-guided solutions, and RTM-augmented solutions. In particular, it found that the therapist-guided solutions justified greater adoption because they showed outcomes on par with in-person treatment at lower cost. For people on commercial insurance, PHTI suggests these solutions could save between $737 and $1,306 per user in the first year. Companies in this category include Sword Health, Hinge Health, Omada Health, Vori, and RecoveryOne

A few details of note: PHTI based its conclusion on an economic analysis of low back pain treatment. It also made some assumptions about uptake in populations and how easier access might lead people to seek care before problems get more expensive to treat. The report also noted that studies of solutions they considered all had a moderate or high risk of bias.

Less than two months ago, PHTI issued a damning report claiming that digital diabetes management tools, including those from Teladoc, Omada, and DarioHealth, aren't worth the money. That report has been criticized for focusing too closely on A1c outcomes in its assessments of clinical efficacy and economic impact.

PHTI's executive director Caroline Pearson said that in part, the positive assessment this time is attributable to the fact that the digital physical therapy solutions can replace existing care, whereas other kinds of digital health tools add cost on top and must demonstrate savings elsewhere to make their case.

So what did companies think this time? Not surprisingly, a few of the companies, like Sword and RecoveryOne, sent statements saying they were happy PHTI was backing up their solutions. 

But Vori offered some observations about how the model might be adapted to show even more savings.

"Impact on worker productivity and absenteeism, prescription drug savings, and ER visit savings do not appear factored into the model," CEO Ryan Grant wrote by email. "Overall, the report is a nice first pass to show that virtual-first solutions can move the needle in terms of savings. Savings can certainly go a lot deeper than what is reported depending on the variables accounted for in the analysis."

Carolyn Jasik, the chief medical officer of Omada, said she believed the report oversimplified its definitions: "PHTI inappropriately puts companies like Omada that offer exclusively physical therapist-provided care in the same category as companies that seem to offer health coach-directed care."

Omada's diabetes solution was dinged in the previous PHTI report, and the company also pointed out what appeared to be differences in methodology between the two.

The American Physical Therapy Association, for its part, issued a statement that was mostly positive, highlighting the need for virtual solutions that augment existing models and address problems with affordability and accessibility of care. It, like Omada, underscored the importance of care delivered by physical therapists.

Do you have thoughts on the latest PHTI report, or related topics? My inbox is open for business: mario.aguilar@statnews.com.



Fundraising

Axena scores funding boost, and other rounds

Axena Health announced it raised an additional $9.4 million to advance commercialization of Leva Pelvic Health System, a smartphone connected biofeedback device that guides users through pelvic floor strengthening exercises to treat urinary and fecal incontinence, bringing the company's Series A funding haul to $30.8 million.

Founded last year, Axena was born from the ashes of Renovia, the company that developed the Leva device but ran out of money. With fresh evidence of positive clinical outcomes, new funding, and a handful of positive payer coverage decisions from Cigna, Highmark Blue Cross Blue Shielf, and Blue Shield of North Dakota, the company's sales reps have spent the last year knocking on OBGYN doors. CFO and interim CEO Jim O'Connor told STAT that the business is making progress: The company booked more than a half million dollars in sales in the first quarter of 2024 and expects bigger numbers for the rest of the year. It hopes to use the new funds to expand to new territories. The company is also investing in developing treatments that can be used in low- and middle-income countries.

In other funding news:

  • Virtual musculoskeletal care company Sword Health raised $130 million in a primary and secondary sale valuing the company at $3 billion. (More details at TechCrunch)
  • Digital stethoscope company Eko Health, which recently received FDA clearance for its algorithm for detecting low-ejection fraction, a sign of heart failure, raised a $41 million in Series D round. (More details at Axios)

More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • What aren't the OpenAI whistleblowers saying?, Platformer
  • Understanding the real threat generative AI poses to our jobs, Blood in the Machine

  • AI is imitating the dead and dying, raising new questions about grieving, Associated Press

Thanks for reading! More on Tuesday - Mario

Mario Aguilar covers how technology is transforming health care. He is based in New York.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments